Banzel Alternatives Compared
| Banzel | Onfi | Clobazam |
|
|---|
| Banzel (rufinamide) | Onfi (clobazam) | Clobazam |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Lennox-Gastaut Syndrome. Banzel may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lennox-Gastaut Syndrome. Onfi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Epilepsy, Lennox-Gastaut Syndrome. clobazam may also be used for purposes not listed in this medication guide. |
Related suggestions Lennox-Gastaut Syndrome
|
|||||||||||||||||||||||
| More about Banzel (rufinamide) | More about Onfi (clobazam) | More about Clobazam | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Banzel has an average rating of 9.5 out of 10 from a total of 6 ratings on Drugs.com. 83% of reviewers reported a positive effect, while 0% reported a negative effect. |
Onfi has an average rating of 5.8 out of 10 from a total of 11 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 36% reported a negative effect. |
Clobazam has an average rating of 6.2 out of 10 from a total of 33 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Common side effects include:
See also: Banzel side effects in more detail. |
Common side effects include:
See also: Onfi side effects in more detail. |
Commonly reported side effects include:
See also: clobazam side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Banzel prices and generic prices |
View all Onfi prices and generic prices |
View all clobazam prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other clobazam brands include: Sympazan | Onfi, Sympazan | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
10 hours |
82 hours |
82 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 469 drugs are known to interact with Banzel:
|
A total of 487 drugs are known to interact with Onfi:
|
A total of 487 drugs are known to interact with clobazam:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
November 14, 2008 |
October 21, 2011 |
October 21, 2011 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.